Solid Carcinoma
Also known as: Solid carcinoma (morphologic abnormality)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00041 | Aldesleukin | 1 | Not Yet Recruiting | 1 |
| DB15254 | Avutometinib | 1 | Recruiting | 1 |
| DB15463 | Belzutifan | 1 | Active Not Recruiting | 1 |
| DB01101 | Capecitabine | 1 | Active Not Recruiting | 1 |
| DB17573 | Evorpacept | 1 | Recruiting | 1 |
| DB17544 | IMM01 | 1 | Not Yet Recruiting | 1 |
| DB00678 | Losartan | 1 | Not Yet Recruiting | 1 |
| DB17309 | Minnelide | 1 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 | Completed | 1 |
| DB00129 | Ornithine | 1 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 | Recruiting | 2 |
| DB14962 | Trastuzumab deruxtecan | 1 | Recruiting | 1 |
| DB11652 | Tucatinib | 1 | Recruiting | 1 |
| DB15471 | Zanidatamab | 1 | Recruiting | 1 |
| DB00544 | Fluorouracil | 1 / 2 | Recruiting | 1 |
| DB00947 | Fulvestrant | 1 / 2 | Completed | 1 |
| DB00650 | Leucovorin | 1 / 2 | Recruiting | 1 |
| DB07101 | Mirdametinib | 1 / 2 | Completed | 1 |
| DB11793 | Niraparib | 1 / 2 | Recruiting | 1 |
| DB00129 | Ornithine | 1 / 2 | Recruiting | 1 |
| DB16186 | PEN-866 | 1 / 2 | Recruiting | 1 |
| DB12023 | Benralizumab | 2 | Active Not Recruiting | 1 |
| DB05332 | Romiplostim | 2 | Terminated | 1 |